TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data ...
News Medical on MSN
Jumping DNA fragments found to destabilize cancer genome
A study published today in the journal Science reveals how jumping fragments of human DNA, a type of genetic parasite, ...
Hidden within cancer DNA data, researchers uncovered viruses and bacteria that may influence both diagnosis and survival.
A study published in the journal Science reveals how jumping fragments of human DNA, a type of genetic parasite, destabilize the cancer genome. Unstable genomes are a fertile playground for cancer ...
Three emerging Māori researchers leading innovative projects to improve cancer outcomes for whānau Māori will receive this ...
At AGBT 2026, Singular Genomics is bringing population-scale spatial to the forefront, spotlighting a foundation-scale colorectal cancer initiative from Weill Cornell Medicine researchers Chris Mason ...
At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions SAN DIEGO, Feb. 26, 2026 ...
A fleeting DNA fold called i‑DNA can switch cancer‑related genes on and off, revealing a hidden structural weak point that ...
Shifting the focus from organ to biomarker has unlocked new options for rare and advanced cancers. Uneven efficacy, diagnostic access, and regulation still slow clinical rollout.
A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...
Bionano Symposium 2026 continues with Day 3: OGM Making its Mark in Constitutional Genetic Disorders on February 25, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 1 of the Bionano Symposium 2026 entitled Advancements in Hematologic Malignancies with Optical Genome Mapping (OGM).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results